Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18474729 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
Condition: Alzheimer Disease
Interventions: Drug: Naproxen Sodium (Aleve);   Drug: Celecoxib (Celebrex)
2 Unknown  Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial
Conditions: Alzheimer Disease;   Dementia
Intervention:

Indicates status has not been verified in more than two years